HHealthcare Read More Novo shares jump 6% as Wegovy pill sales impress, drugmaker hikes outlookNovember 4, 2026 Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates…
HHealthcare Read More Eli Lilly (LLY) earnings Q3 2026October 29, 2026 Eli Lilly on Thursday reported third-quarter earnings and revenue that blew past estimates and hiked its full-year sales…
MMedication Read More Novo’s Wegovy pill improves weight loss after switch from injectionsSeptember 30, 2026 People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…
MMedication Read More Ozempic counterfeit ring charges against Indian nationals unsealedSeptember 29, 2026 Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…
HHealthcare Read More Lilly is ramping up future manufacturing for Foundayo obesity pillSeptember 21, 2026 Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…
HHealthcare Read More Novo Nordisk rebrands to ‘Novo’ under CEO Mike DoustdarSeptember 14, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
HHealthcare Read More This medical device stock looks like a gift for patient investorsSeptember 1, 2026 Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…
HHealthcare Read More Novo Nordisk CEO defends lawsuit against Eli Lilly: ‘Competition has to be fair’August 13, 2026 Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…
HHealthcare Read More Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 marketAugust 6, 2026 The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…
HHealthcare Read More We’re increasing our Eli Lilly price target after another beat-and-raise quarterAugust 5, 2026 Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…
HHealthcare Read More Eli Lilly (LLY) earnings Q2 2026August 5, 2026 Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook,…
HHealthcare Read More Novo Nordisk releases earnings and guidanceAugust 4, 2026 Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…